Data and materials availability Upon request, and subject to certain criteria, conditions, and exceptions (see for more information), Pfizer will provide access to individual de-identified participant data from Pfizer-sponsored global interventional clinical studies conducted for medicines, vaccines and medical devices (1) for indications that have been approved in the US and/or EU or (2) in programs that have been terminated (i.e., development for all indications has been discontinued)
C.LeeP.ZhangT.van den BroekN
Given its scale, Empower is likely used by additional platforms that do not publicly disclose their pharmacy partners by name
A 30-week dose of GLP-1 results in a 3.3 percent loss of weight and a drop in blood glucose A1C of 0.32 percentage points, changes that closely match clinical trial results
All oral tirzepatide drops, tablets, and troches are compounded products that have not undergone FDA safety and efficacy review